These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30273512)

  • 21. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine.
    Sun M; Ma Y; Xu Y; Yang H; Shi L; Che Y; Liao G; Jiang S; Zhang S; Li Q
    Vaccine; 2014 Feb; 32(9):1100-6. PubMed ID: 24412578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
    Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test.
    Arita M; Iwai-Itamochi M
    Sci Rep; 2022 Sep; 12(1):16074. PubMed ID: 36167892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An adjuvant compound that enhances immunogenicity at fractional doses of the Sabin-inactivated poliovirus vaccine (sIPV) with a long duration of protection in a rat model.
    Song S; Liu Z; Zhou J; Cai W; Yang H; Ma L; Gao J; Li W; Liao G
    J Med Virol; 2019 Jan; 91(1):14-21. PubMed ID: 30168587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
    Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
    Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial.
    Chu K; Ying Z; Wang L; Hu Y; Xia J; Chen L; Wang J; Li C; Zhang Q; Gao Q; Hu Y
    Vaccine; 2018 Oct; 36(45):6782-6789. PubMed ID: 30249424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
    Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
    J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enhancing the immunogenicity of inactivated polio vaccines with chitosan used as an adjuvant].
    Gendon IuZ; Markushin SG; Akopova II; Krivtsov GG; Akhmatova NK; Koptiaeva IB; Vasil'ev IuM
    Vopr Virusol; 2011; 56(6):28-32. PubMed ID: 22359946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.
    Bakker WA; Thomassen YE; van't Oever AG; Westdijk J; van Oijen MG; Sundermann LC; van't Veld P; Sleeman E; van Nimwegen FW; Hamidi A; Kersten GF; van den Heuvel N; Hendriks JT; van der Pol LA
    Vaccine; 2011 Sep; 29(41):7188-96. PubMed ID: 21651934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
    Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
    mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenicity and safety of a booster dose of inactivated polio vaccine].
    Li XM; Zhang ZJ; Wang HH; Liu F; Zhang LW; Chu P; Xu Y; Zhang HR; Li J; Liu DL; Lu L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):905-9. PubMed ID: 24378129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains.
    Martín J; Crossland G; Wood DJ; Minor PD
    J Gen Virol; 2003 Jul; 84(Pt 7):1781-1788. PubMed ID: 12810872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poliovirus neutralization test with poliovirus pseudovirus to measure neutralizing antibody in humans.
    Arya SC; Agarwal N
    Clin Vaccine Immunol; 2012 Mar; 19(3):458; author reply 459. PubMed ID: 22371252
    [No Abstract]   [Full Text] [Related]  

  • 38. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum.
    Jin J; Ma H; Xu L; An D; Sun S; Huang X; Kong W; Jiang C
    J Virol Methods; 2013 Feb; 187(2):362-7. PubMed ID: 23178532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
    Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.